Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:54:56 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Bright Minds Biosciences Inc (2)
Symbol DRUG
Shares Issued 4,433,837
Close 2024-01-16 C$ 2.69
Market Cap C$ 11,927,022
Recent Sedar+ Documents

Bright Minds holder McDonald's holdings up to 19.6%

2024-01-18 20:34 ET - News Release

Subject: Bright Minds Biosciences Inc. - Early Warning News Release Word Document File: '\\swfile\EmailIn\20240118 172756 Attachment Bright Minds - Early Warning News Release - I. McDonald.docx' LEGAL_42964811.2 LEGAL_42964811.2 EARLY WARNING REPORT ISSUED PURSUANT TO NATIONAL INSTRUMENT 62-103 - ACQUISITION OF SECURITIES OF SPANISH MOUNTAIN GOLD LTD. January 18, 2024 CSE: DRUG; NASDAQ: DRUG VANCOUVER, BC. - This news release is related the securities of Bright Minds Biosciences Inc. ("Bright Minds" or the "Company"). Ian McDonald (the "Acquiror") announces that he acquired 661,765 units of the Company (the "Units") at a price of $1.36 per Unit in a non-brokered private placement completed by the Company for a total subscription price of $900,000.40 (the "Private Placement"). Each Unit is comprised of one common share in the capital of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant entitles the holder to acquire one additional Common Share (a "Warrant Share") at a price of $1.70 per Warrant Share for a period of 60 months from the closing date of the Private Placement. Immediately prior to the Private Placement, the Acquiror owned an aggregate of 212,980 Common Shares, representing approximately 5.6% of the issued and outstanding Common Shares of the Company on an undiluted basis. Following completion of the Private Placement, the Acquiror owns an aggregate of 874,745 Common Shares, representing approximately 19.6% of the issued and outstanding Common Shares on an undiluted basis. The Acquiror also owns (i) an aggregate of 661,765 Warrants as part of the purchase of the Units, entitling the Acquiror to purchase 661,765 Common Shares, and (ii) 60,000 restricted share units ("RSUs") to acquire 60,000 Common Shares (50% of which vest on December 2, 2024 and 50% of which vest on December 2, 2025). If the Acquiror exercises all of his Warrants and RSUs he would then own 1,596,510 Common Shares, representing approximately 30.79% of the issued and outstanding Common Shares of the Company on a partially diluted basis. The Private Placement resulted in an approximately 14% change in the Acquiror's ownership over Common Shares of the Company on an undiluted basis. The Acquiror acquired the Units for investment purposes under an exemption provided under National Instrument 45-106 - Prospectus Exemptions. The Acquiror may, depending on market and other conditions, increase or decrease his ownership of the Company's securities, whether in the open market, by privately negotiated agreements or otherwise, subject to a number of factors, including general market conditions and other available investment and business opportunities. For further information, or to obtain a copy of the Early Warning Report filed under applicable securities laws, please contact Ian McDonald at (647) 407-2515.

© 2026 Canjex Publishing Ltd. All rights reserved.